Mark J. Enyedy is CEO at ImmunoGen, Inc. (IMGN). They have made 5 open-market trades across 1 company since 2016, most recently 2026-06-02.
CIK 0001586965
1 open-market purchase totalling $46K since 2016, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IMGN | SELL · 10b5-1 | 2024-02-05 | 2024-02-06 | $29.28 | $1.2M | N/A | N/A | N/A |
| IMGN | SELL | 2023-08-02 | 2023-08-04 | $17.09 | $85.3M | -4.2% | -8.0% | -7.7% |
| IMGN | SELL | 2020-02-24 | 2020-02-25 | $4.99 | $551K | -12.9% | -26.4% | +1.4% |
| IMGN | SELL | 2018-02-22 | 2019-02-25 | $5.60 | $286K | -55.8% | -57.1% | -67.1% |
| IMGN | SELL | 2018-02-21 | 2018-02-23 | $10.87 | $1.5M | +3.9% | +15.5% | -5.6% |
| IMGN | BUY | 2016-11-08 | 2016-11-09 | $1.83 | $46K | -2.3% | -13.6% | +11.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.